Open call for tenders
Kasvajavastased ja immunomoduleerivad ained (Pärnu Haigla)
Pharmaceutical products · for Sihtasutus Pärnu Haigla · Estonia · published in Estonian
What the buyer wants
Riigihanke eesmärgiks on sõlmida raamlepingud, mille objektiks on SA-le Pärnu Haigla kasvajavastaste ja immunomoduleerivate ainete ostmine, mille tehniline kirjeldus ja eeldatavad kogused on esitatud HD lisas 1. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
30 lots
- Palivizumab
- Dakarbasiin
- Etoposiid
- Epirubitsiin
- Obinutuzumab
- Daratumumab
- Pertuzumab
- Trastuzumabemtansiin
- Trastuzumabderukstekaan
- Panitumumab
- Nivolumab
- Pembrolizumab
- Durvalumab
- Avelumab
- Atesolizumab
- Tsemiplimab
- Brentuksimabvedotiin
- Pertuzumab+trastuzumab
- Karfilsomib
- Tsütarabiin+daunorubitsiin
- Filgrastiim
- Pegfilgrastiim
- Abatatsept
- Golimumab
- Ustekinumab
- Sarilumab
- Guselkumab
- Risankizumab
- Mirikizumab
- Belimumab
Companies that won similar tenders
Companies that won public tenders in the same category (Pharmaceutical products) since 2024, according to EU award notices. Likely competitors, or partners for a joint offer.
- Myhrabc · Czechia541 wins · last 2 Nov 2026
- pharmos.cz · Czechia394 wins · last 3 Nov 2026
- Novartis · Czechia10 wins · last 2 Nov 2026
- Janssen-Cilag · United Kingdom6 wins · last 16 May 2025
- Substipharm · France4 wins · last 13 Aug 2025
- Panpharma · France4 wins · last 16 May 2025
- Grindeks Kalceks Suomi · Finland3 wins · last 8 Sep 2026
- lekarnalemon.cz · Czechia3 wins · last 8 Jul 2026
- Provepharm · France3 wins · last 16 May 2025
- Lso Medical · France2 wins · last 13 Mar 2025
- Aspironix · Czechia1 win · last 28 May 2026
- lekarna.cz · Czechia1 win · last 29 Sep 2025
and 4 more.